FSD Pharma Inc. (HUGE) concluded trading on 08/27/20 at a closing price of $3.05, with 1.32 million shares of worth about $4.03 million changed hands on the day. Weekly performance of the stock remained negative as price took a plunge of 0.00% during that period and on Thursday the price saw a gain of about 7.39%. Currently the company’s common shares owned by public are about 12.98M shares, out of which, 11.46M shares are available for trading.
The company recently came buying 0.0 shares which brought its stake up to 0.29% of the company’s outstanding shares.
FSD Pharma Inc. (NASDAQ: HUGE) started trading at $2.87, above $0.03 from concluding price of the previous day. However, the stock finished the trading on the day at a closing price of $3.05, or with a gain of 7.39%. Stock saw a price change of 0.00% in past 5 days and over the past one month there was a price change of -18.45%. Year-to-date (YTD), HUGE shares are showing a performance of -43.82% which decreased to -82.34% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.39 but also hit the highest price of $17.49 during that period. While comparing its average daily trading volume of 912.48K shares, we see that about 1.32 million changed hands on the day. The stock is currently trading -0.64% below its 20-day simple moving average (SMA20), while that difference is down -14.48% for SMA50 and it goes to -29.99% lower than SMA200.
Holding of mutual funds in the company is about — while other institutional holders and individual stake holders have control over — and — of the stake respectively.
The stock has a current market capitalization of $39.60M. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HUGE, volatility over the week remained 8.77% while standing at 11.29% over the month.
Analysts at 1 brokerage firms have issued recommendations for the FSD Pharma Inc. (HUGE)’s stock out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.